Results
Marksans Pharma FY26 Net Profit Rises 60% YoY
Marksans Pharma reported audited FY26 standalone net profit of ₹3,007 million, a 60% increase from the previous year.
Consolidated revenue for FY26 reached ₹29,509 million, with a net profit attributa
